The Influence of Pro-inflammatory Cytokines and Genetic Variants in the Development of Fibromyalgia: A Traditional Review

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2020 Oct 12

PMID 33042712

Citations 12

Authors

Mercedes Maria Peck

Ruchira Maram

Alaa Mohamed

Diego Ochoa Crespo

Gurleen Kaur

Ibtisam Ashraf

Bilal Haider Malik

Affiliations

Soon will be listed here.

Abstract

Fibromyalgia is a complex syndrome characterized by widespread chronic pain, without any obvious etiology, and it is often accompanied by a constellation of symptoms such as fatigue, sleep disturbances and cognitive dysfunction, to name a few. The syndrome may be associated with a variety of autoimmune and psychiatric conditions. Fibromyalgia can occur with other musculoskeletal pathologies and its symptoms can overlap with other chronic painful conditions such as chronic myofascial pain syndromes seen in cervical and lumbar spinal osteoarthritis and degenerative disc disease. Gene polymorphisms have been related to a decreased pain threshold and an increased susceptibility to disorders associated with chronic pain. Some of those genetic variants might trigger the onset of fibromyalgia. Researchers are looking into the possible factors that might contribute to its pathophysiology. It is important to study the connections between pro-inflammatory cytokines and genetic variants in pain-related genes and their roles in predisposition and development of fibromyalgia. The objective of this review article is to provide a brief overview of the pro-inflammatory cytokines commonly associated with fibromyalgia, as well as to look into the genes that have shown some level of involvement in the development of fibromyalgia and its symptomatology.

Citing Articles

Electroacupuncture Modulates Programmed Cell Death 1 Ligand 1 on Peripheral and Central Nervous Systems in a Mouse Fibromyalgia Pain Model.

Lin H, Hsu H, Liao H, Chen A, Lin Y Biomedicines. 2025; 13(2).

PMID: 40002809 PMC: 11853732. DOI: 10.3390/biomedicines13020396.

Is middle East pain syndrome (MEPS) a variant of fibromyalgia syndrome or a distinct disease?.

Elhamamy M, Elbeialy A, Mohamed M, Abdelraheem S, Elzomor H BMC Rheumatol. 2025; 9(1):3.

PMID: 39780200 PMC: 11708104. DOI: 10.1186/s41927-024-00428-0.

Electroacupuncture Reduced Fibromyalgia-Pain-like Behavior through Inactivating Transient Receptor Potential V1 and Interleukin-17 in Intermittent Cold Stress Mice Model.

Yeh Y, Liao H, Hsiao I, Hsu H, Lin Y Brain Sci. 2024; 14(9).

PMID: 39335365 PMC: 11430684. DOI: 10.3390/brainsci14090869.

Proteomics in Patients with Fibromyalgia Syndrome: A Systematic Review of Observational Studies.

Gkouvi A, Tsiogkas S, Bogdanos D, Gika H, Goulis D, Grammatikopoulou M Curr Pain Headache Rep. 2024; 28(7):565-586.

PMID: 38652420 PMC: 11271354. DOI: 10.1007/s11916-024-01244-4.

Psoriasis and Fibromyalgia: A Systematic Review.

DOnghia M, Ursini F, Cinotti E, Calabrese L, Tognetti L, Cartocci A J Pers Med. 2024; 14(2).

PMID: 38392598 PMC: 10890434. DOI: 10.3390/jpm14020165.

References

Monin L, Gaffen S . Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications. Cold Spring Harb Perspect Biol. 2017; 10(4). PMC: 5732092. DOI: 10.1101/cshperspect.a028522. View

Tsilioni I, Russell I, Stewart J, Gleason R, Theoharides T . Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells. J Pharmacol Exp Ther. 2016; 356(3):664-72. PMC: 4767394. DOI: 10.1124/jpet.115.230060. View

Arout C, Sofuoglu M, Bastian L, Rosenheck R . Gender Differences in the Prevalence of Fibromyalgia and in Concomitant Medical and Psychiatric Disorders: A National Veterans Health Administration Study. J Womens Health (Larchmt). 2018; 27(8):1035-1044. PMC: 6425926. DOI: 10.1089/jwh.2017.6622. View

Christidis N, Ghafouri B, Larsson A, Palstam A, Mannerkorpi K, Bileviciute-Ljungar I . Comparison of the Levels of Pro-Inflammatory Cytokines Released in the Vastus Lateralis Muscle of Patients with Fibromyalgia and Healthy Controls during Contractions of the Quadriceps Muscle--A Microdialysis Study. PLoS One. 2015; 10(12):e0143856. PMC: 4666439. DOI: 10.1371/journal.pone.0143856. View

Meester I, Rivera-Silva G, Gonzalez-Salazar F . Immune System Sex Differences May Bridge the Gap Between Sex and Gender in Fibromyalgia. Front Neurosci. 2020; 13:1414. PMC: 6978848. DOI: 10.3389/fnins.2019.01414. View

Kutu F, Ozdolap S, Sarikaya S . Pro-inflammatory Cytokines and Oxidized Low-Density-Lipoprotein in Patients With Fibromyalgia. Arch Rheumatol. 2019; 34(2):123-129. PMC: 6719580. DOI: 10.5606/ArchRheumatol.2019.6733. View

Banfi G, Diani M, Pigatto P, Reali E . T Cell Subpopulations in the Physiopathology of Fibromyalgia: Evidence and Perspectives. Int J Mol Sci. 2020; 21(4). PMC: 7072736. DOI: 10.3390/ijms21041186. View

Clos-Garcia M, Andres-Marin N, Fernandez-Eulate G, Abecia L, Lavin J, van Liempd S . Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia. EBioMedicine. 2019; 46:499-511. PMC: 6710987. DOI: 10.1016/j.ebiom.2019.07.031. View

McGeachy M, Cua D, Gaffen S . The IL-17 Family of Cytokines in Health and Disease. Immunity. 2019; 50(4):892-906. PMC: 6474359. DOI: 10.1016/j.immuni.2019.03.021. View

10.

Wolfe F, Brahler E, Hinz A, Hauser W . Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res (Hoboken). 2013; 65(5):777-85. DOI: 10.1002/acr.21931. View

11.

Kosek E, Martinsen S, Gerdle B, Mannerkorpi K, Lofgren M, Bileviciute-Ljungar I . The translocator protein gene is associated with symptom severity and cerebral pain processing in fibromyalgia. Brain Behav Immun. 2016; 58:218-227. DOI: 10.1016/j.bbi.2016.07.150. View

12.

Ernberg M, Christidis N, Ghafouri B, Bileviciute-Ljungar I, Lofgren M, Bjersing J . Plasma Cytokine Levels in Fibromyalgia and Their Response to 15 Weeks of Progressive Resistance Exercise or Relaxation Therapy. Mediators Inflamm. 2018; 2018:3985154. PMC: 5932448. DOI: 10.1155/2018/3985154. View

13.

Ryabkova V, Churilov L, Shoenfeld Y . Neuroimmunology: What Role for Autoimmunity, Neuroinflammation, and Small Fiber Neuropathy in Fibromyalgia, Chronic Fatigue Syndrome, and Adverse Events after Human Papillomavirus Vaccination?. Int J Mol Sci. 2019; 20(20). PMC: 6834318. DOI: 10.3390/ijms20205164. View

14.

Theoharides T, Tsilioni I, Bawazeer M . Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome. Front Cell Neurosci. 2019; 13:353. PMC: 6687840. DOI: 10.3389/fncel.2019.00353. View

15.

Kang S, Tanaka T, Narazaki M, Kishimoto T . Targeting Interleukin-6 Signaling in Clinic. Immunity. 2019; 50(4):1007-1023. DOI: 10.1016/j.immuni.2019.03.026. View

16.

Kuwabara T, Ishikawa F, Kondo M, Kakiuchi T . The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases. Mediators Inflamm. 2017; 2017:3908061. PMC: 5337858. DOI: 10.1155/2017/3908061. View

17.

Castoro R, Simmons M, Ravi V, Huang D, Lee C, Sergent J . Arg225Cys mutation causes nociceptive pain without detectable peripheral nerve pathology. Neurol Genet. 2018; 4(4):e255. PMC: 6055356. DOI: 10.1212/NXG.0000000000000255. View

18.

Zhang H, Li F, Li W, Stary C, Clark J, Xu S . The inflammasome as a target for pain therapy. Br J Anaesth. 2016; 117(6):693-707. PMC: 5155560. DOI: 10.1093/bja/aew376. View

19.

Sanada K, Alda Diez M, Valero M, Perez-Yus M, Demarzo M, Garcia-Toro M . Effects of non-pharmacological interventions on inflammatory biomarker expression in patients with fibromyalgia: a systematic review. Arthritis Res Ther. 2015; 17:272. PMC: 4584481. DOI: 10.1186/s13075-015-0789-9. View

20.

Lee C, Liptan G, Kantorovich S, Sharma M, Brenton A . Association of Catechol--methyltransferase single nucleotide polymorphisms, ethnicity, and sex in a large cohort of fibromyalgia patients. BMC Rheumatol. 2019; 2:38. PMC: 6390547. DOI: 10.1186/s41927-018-0045-4. View